A coalition of unions, consumer groups and public interest organizations on Thursday expressed their concerns over Novo Holdings’ proposed $16.5 billion acquisition of CDMO giant Catalent, citing the growing vertical integration in the healthcare industry and its potential negative effects on patient access to affordable treatments. In their letter,...